Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZTlido Adhesion vs OTC Lidocaine Patches in Healthy Adults
NCT05106400Phase 1Completed
- Sponsor
- Scilex Holding
- Start
- Jul 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lidocaine topical system in postherpetic neuralgia (PHN) (4 arms), sponsored by Scilex Holding. Primary endpoint: Change in Percent adhesion at 12 hours. Started Jul 2021; status: completed.
02
Drugs
lidocaine topical system
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT05106400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05106400.